30 June 2021
Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
8 June 2021
Professor Yang Shi’s group demonstrates that combining drugs targeting epigenetic and metabolic pathways can overcome the arrest of white blood cell differentiation in this blood cancer.
2 June 2021
Ludwig Oxford’s Dr Linna Zhou will investigate the role of the nervous system in cancer progression using engineered gastrointestinal tissues.
26 May 2021
A multidisciplinary team, comprising Ludwig Oxford’s Professor Jens Rittscher with Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
25 May 2021
Ludwig Oxford are delighted to welcome this acclaimed scientist to the Branch and the Oxford community.
7 May 2021
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
4 May 2021
Dr Francesco Boccellato investigates how growth factors influence differentiation and patterning in human gastric glands.
28 April 2021
Dr Chunxiao Song’s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
22 April 2021
Dr Pedro Moura Alves described how the aryl hydrocarbon receptor senses bacteria to fine-tune the body’s response to infection
7 April 2021
Activation of hypoxia inducible factors (HIFs) by either hypoxia or drug treatment inhibits SARS-CoV-2 entry and replication in lung epithelial cells, raising the potential of using clinically licensed HIF activators to prevent and/or treat COVID-19.
2 March 2021
Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.
17 February 2021
Germline and somatic variants in the p53 pathway cooperate to influence cancer risk, progression and response to therapy.
11 February 2021
Ludwig Oxford Director Professor Xin Lu features in this showcase of women in diverse roles across Oxford’s Medical Sciences Division.